Direxion Shares ETF Trust (LABU)
Management Company · ARCX · Series S000049373 · View on SEC EDGAR ↗
- Net assets
- $518.9M
- Holdings
- 161
- As of
- April 30, 2026 stale
- Top 10 holdings weight
- 27.25%
- Effective number of positions
- 53.2
- Positions above 1%
- 19
On this page
- Fund flows Money flowing in and out of the fund each month, from N-PORT filings.
- Holdings Every position the fund currently holds, with weights.
- Sector breakdown How the fund's holdings split across market sectors.
- Institutional owners 13F institutions that report holding this ETF.
- Similar funds Other funds with overlapping holdings or comparable size.
Fund flows (SEC-reported)
- Last month (Apr 2026)
- -$78.1M
- Quarter ending Apr 2026
- -$110.0M
- Trailing 12 months
- -$927.6M
May 2025 – Apr 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 161 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC | 90400D108 | $4.4M | 0.85 | 178,057 | EC | US |
| ACADIA PHARMACEUTICALS INC | 004225108 | $4.4M | 0.85 | 195,542 | EC | US |
| Rhythm Pharmaceuticals Inc | 76243J105 | $4.4M | 0.85 | 53,930 | EC | US |
| Gilead Sciences Inc. | 375558103 | $4.4M | 0.84 | 33,255 | EC | US |
| Biomarin Pharmaceutical Inc. | 09061G101 | $4.3M | 0.84 | 80,485 | EC | US |
| Viking Therapeutics Inc. | 92686J106 | $4.2M | 0.82 | 135,757 | EC | US |
| VERTEX PHARMACEUTICALS INC | 92532F100 | $4.2M | 0.81 | 9,860 | EC | US |
| ImmunityBio Inc | 45256X103 | $4.2M | 0.80 | 587,041 | EC | US |
| Immunovant Inc | 45258J102 | $4.0M | 0.77 | 147,047 | EC | US |
| Moderna Inc | 60770K107 | $4.0M | 0.77 | 86,741 | EC | US |
| Vera Therapeutics Inc. | 92337R101 | $3.9M | 0.75 | 109,557 | EC | US |
| Immunome Inc | 45257U108 | $3.9M | 0.74 | 168,145 | EC | US |
| Disc Medicine Inc | 254604101 | $3.8M | 0.74 | 57,978 | EC | US |
| Veracyte Inc | 92337F107 | $3.7M | 0.71 | 112,171 | EC | US |
| Sarepta Therapeutics Inc | 803607100 | $3.7M | 0.70 | 175,121 | EC | US |
| Catalyst Pharmaceuticals Inc. | 14888U101 | $3.7M | 0.70 | 129,949 | EC | US |
| BIOCRYST PHARMACEUTICALS INC | 09058V103 | $3.5M | 0.67 | 381,305 | EC | US |
| Dyne Therapeutics Inc. | 26818M108 | $3.5M | 0.67 | 196,941 | EC | US |
| Kodiak Sciences Inc | 50015M109 | $3.3M | 0.64 | 76,962 | EC | US |
| RECURSION PHARMACEUTICALS INC | 75629V104 | $3.3M | 0.64 | 958,574 | EC | US |
| GRAIL Inc | 384747101 | $3.2M | 0.63 | 59,651 | EC | US |
| Unknown security | — | $3.2M | 0.62 | 1 | DE | US |
| Arcus Biosciences Inc. | 03969F109 | $3.2M | 0.61 | 123,926 | EC | US |
| Agios Pharmaceuticals Inc | 00847X104 | $3.1M | 0.60 | 110,585 | EC | US |
| Denali Therapeutics Inc | 24823R105 | $3.0M | 0.59 | 162,191 | EC | US |
| Unknown security | — | $3.0M | 0.58 | 1 | DE | US |
| Oruka Therapeutics Inc | 687604108 | $3.0M | 0.57 | 43,576 | EC | US |
| Dianthus Therapeutics Inc | 252828108 | $3.0M | 0.57 | 33,605 | EC | US |
| Intellia Therapeutics Inc | 45826J105 | $2.9M | 0.56 | 215,007 | EC | US |
| Erasca Inc | 29479A108 | $2.9M | 0.56 | 271,194 | EC | US |
| ADMA BIOLOGICS INC | 000899104 | $2.9M | 0.56 | 281,674 | EC | US |
| Syndax Pharmaceuticals Inc. | 87164F105 | $2.9M | 0.55 | 134,242 | EC | US |
| Ardelyx Inc | 039697107 | $2.8M | 0.54 | 438,991 | EC | US |
| IDEAYA Biosciences Inc. | 45166A102 | $2.7M | 0.52 | 93,300 | EC | US |
| Mineralys Therapeutics Inc. | 603170101 | $2.7M | 0.52 | 101,556 | EC | US |
| Nurix Therapeutics Inc. | 67080M103 | $2.7M | 0.52 | 160,937 | EC | US |
| Tango Therapeutics Inc. | 87583X109 | $2.4M | 0.47 | 112,975 | EC | US |
| Celldex Therapeutics Inc. | 15117B202 | $2.3M | 0.44 | 70,017 | EC | US |
| CAPRICOR THERAPEUTICS INC | 14070B309 | $2.3M | 0.43 | 67,108 | EC | US |
| Vericel Corporation | 92346J108 | $2.2M | 0.43 | 63,931 | EC | US |
| Inhibrx Biosciences Inc. | 45720N103 | $2.2M | 0.42 | 16,961 | EC | US |
| Monte Rosa Therapeutics Inc | 61225M102 | $2.2M | 0.42 | 112,609 | EC | US |
| Novavax Inc | 670002401 | $2.1M | 0.41 | 267,379 | EC | US |
| Biohaven Ltd | G1110E107 | $2.1M | 0.41 | 220,160 | EC | VG |
| Stoke Therapeutics Inc | 86150R107 | $2.1M | 0.41 | 64,471 | EC | US |
| Relay Therapeutics Inc | 75943R102 | $2.1M | 0.40 | 162,116 | EC | US |
| Taysha Gene Therapies Inc. | 877619106 | $2.1M | 0.40 | 322,791 | EC | US |
| Viridian Therapeutics Inc | 92790C104 | $2.1M | 0.40 | 152,815 | EC | US |
| Olema Pharmaceuticals Inc. | 68062P106 | $2.0M | 0.39 | 141,558 | EC | US |
| Palvella Therapeutics Inc. | 697947109 | $2.0M | 0.39 | 15,705 | EC | US |
Page 2
of 4
Sector breakdown
Healthcare
77.1%
Other/Unmapped
22.9%
Institutional owners (13F) 40 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | $89,616,280 | 20.41% | 306,800 | Put option | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $83,073,240 | 18.92% | 284,400 | Call option | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $80,824,070 | 18.40% | 276,700 | Put option | June 30, 2026 |
| JANE STREET GROUP, LLC | $59,938,920 | 13.65% | 205,200 | Put option | June 30, 2026 |
| CITADEL ADVISORS LLC | $46,794,420 | 10.66% | 160,200 | Call option | June 30, 2026 |
| JANE STREET GROUP, LLC | $25,938,480 | 5.91% | 88,800 | Call option | June 30, 2026 |
| GOLDMAN SACHS GROUP INC | $17,126,991 | 3.90% | 58,634 | Shares | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9,585,262 | 2.18% | 32,815 | Shares | June 30, 2026 |
| Tower Research Capital LLC (TRC) | $6,295,047 | 1.43% | 21,551 | Shares | June 30, 2026 |
| GTS SECURITIES LLC | $5,100,066 | 1.16% | 17,460 | Shares | June 30, 2026 |
| TWO SIGMA SECURITIES, LLC | $1,771,294 | 0.40% | 6,064 | Shares | June 30, 2026 |
| Bank of New York Mellon Corp | $1,533,525 | 0.35% | 5,250 | Shares | June 30, 2026 |
| McGuire Investment Group, LLC | $1,525,638 | 0.35% | 5,223 | Shares | June 30, 2026 |
| CIBC Bancorp USA Inc. | $1,387,475 | 0.32% | 4,750 | Shares | June 30, 2026 |
| Allworth Financial LP | $1,234,123 | 0.28% | 4,225 | Shares | June 30, 2026 |
| Ethos Financial Group, LLC | $968,312 | 0.22% | 3,315 | Shares | June 30, 2026 |
| Walleye Trading LLC | $788,670 | 0.18% | 2,700 | Put option | June 30, 2026 |
| SBI Securities Co., Ltd. | $675,043 | 0.15% | 2,311 | Shares | June 30, 2026 |
| JANE STREET GROUP, LLC | $561,124 | 0.13% | 1,921 | Shares | June 30, 2026 |
| Walleye Trading LLC | $531,914 | 0.12% | 1,821 | Shares | June 30, 2026 |
| BANK OF AMERICA CORP /DE/ | $478,752 | 0.11% | 1,639 | Shares | June 30, 2026 |
| Valued Retirements, Inc. | $454,216 | 0.10% | 1,555 | Shares | June 30, 2026 |
| HighTower Advisors, LLC | $408,940 | 0.09% | 1,400 | Shares | June 30, 2026 |
| CIBC Private Wealth Group LLC | $351,038 | 0.08% | 3,750 | Shares | Sept. 30, 2025 |
| Simmons Bank | $349,060 | 0.08% | 1,195 | Shares | June 30, 2026 |
| Variant Private Wealth, LLC | $319,164 | 0.07% | 1,093 | Shares | June 30, 2026 |
| UBS Group AG | $297,942 | 0.07% | 1,020 | Shares | June 30, 2026 |
| HALBERT HARGROVE GLOBAL ADVISORS, LLC | $292,100 | 0.07% | 1,000 | Shares | June 30, 2026 |
| MILLENNIUM MANAGEMENT LLC | $292,100 | 0.07% | 1,000 | Shares | June 30, 2026 |
| XTX Topco Ltd | $274,574 | 0.06% | 940 | Shares | June 30, 2026 |
| Sheaff Brock Investment Advisors, LLC | $243,880 | 0.06% | 4,000 | Shares | March 31, 2025 |
| JPMORGAN CHASE & CO | $66,503 | 0.02% | 228 | Shares | June 30, 2026 |
| Steward Partners Investment Advisory, LLC | $29,210 | 0.01% | 100 | Shares | June 30, 2026 |
| BANK OF MONTREAL /CAN/ | $14,605 | 0.00% | 50 | Shares | June 30, 2026 |
| PayPay Securities Corp | $11,976 | 0.00% | 41 | Shares | June 30, 2026 |
| Larson Financial Group LLC | $8,937 | 0.00% | 31 | Shares | June 30, 2026 |
| MATHER GROUP, LLC. | $3,861 | 0.00% | 13 | Shares | June 30, 2026 |
| TORONTO DOMINION BANK | $2,576 | 0.00% | 9 | Shares | June 30, 2026 |
| Spire Wealth Management | $1,183 | 0.00% | 4 | Shares | June 30, 2026 |
| Covestor Ltd | $76 | 0.00% | 261 | Shares | June 30, 2026 |
Peer funds
More from this issuer
| Fund | AUM |
|---|---|
| SOXL Direxion Shares ETF Trust | $16.9B |
| SPXL Direxion Shares ETF Trust | $5.9B |
| TSLL Direxion Shares ETF Trust | $5.0B |
| TECL Direxion Shares ETF Trust | $4.7B |
| TMF Direxion Shares ETF Trust | $2.7B |
| FAS Direxion Shares ETF Trust | $2.0B |
| SOXS Direxion Shares ETF Trust | $1.9B |
| KORU Direxion Shares ETF Trust | $1.6B |
| TNA Direxion Shares ETF Trust | $1.5B |
| MUU Direxion Shares ETF Trust | $1.4B |
Similar by size
| Fund | AUM |
|---|---|
| FDHY Fidelity Covington Trust | $521.9M |
| IDGT iShares Trust | $522.0M |
| DDM ProShares Trust | $523.4M |
| CSM ProShares Trust | $524.0M |
| MSTU ETF Opportunities Trust | $525.4M |
| FNY First Trust Exchange-Traded Alp… | $518.2M |
| VBND ETF Series Solutions | $510.2M |
| FDEM Fidelity Covington Trust | $508.1M |
| LQDH iShares U.S. ETF Trust | $505.8M |
| QFLR Innovator ETFs Trust | $505.6M |